Ben Busby

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (2)

• The third international hackathon for applying insights into large-scale genomic composition to use cases in a wide range of organisms.
  2022 L1 59/100
• Viewing RNA-seq data on the entire human genome.
  2017 L1 50/100

2 assessed by us (0 reproduced) · 160 not yet assessed — every PubMed paper on record, linked below.

• Towards Federated Learning Across Biobanks: Prototype Software from the 2026 Carnegie Mellon University–NVIDIA Hackathon ↗

  2026
  not yet assessed
• Towards Federated Learning Across Biobanks: Prototype Software from the 2026 Carnegie Mellon University–NVIDIA Hackathon

  BioHackrXiv (OSF Preprints) · 2026
  not yet assessed
• The challenge of chromatin model comparison and validation: A project from the first international 4D Nucleome Hackathon ↗

  PLoS Computational Biology · 2025 · PMID 40828848
  not yet assessed
• Sixth Annual BCM Hackathon on Structural Variation and Pangenomics ↗

  F1000Research · 2025
  not yet assessed
• A Blueprint for Open Science: How Transatlantic Teams Built and Deployed Knowledge Graphs to Enable Biological (AI) Models ↗

  2025
  not yet assessed
• Correction: An international consensus on effective, inclusive, and career-spanning short-format training in the life sciences and beyond ↗

  PLoS ONE · 2025 · PMID 39977432
  not yet assessed
• Addressing Background Genomic and Environmental Effects on Health through Accelerated Computing and Machine Learning: Results from the 2025 Hackathon at Carnegie Mellon University ↗

  2025
  not yet assessed
• Oncomatch- Optimizing Oncology Combination Therapy Prediction ↗

  2025
  not yet assessed
• AI for Computational Biology: Highlights from the first BioAI Hackathon at University of Warsaw ↗

  2025
  not yet assessed
• The GIAB genomic stratifications resource for human reference genomes ↗

  Nature Communications · 2024 · PMID 39424793
  not yet assessed
• Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  Clinical Cancer Research · 2024 · PMID 38446993
  not yet assessed
• The fifth international hackathon for developing computational cloud-based tools and resources for pan-structural variation and genomics ↗

  F1000Research · 2024
  not yet assessed
• A reassessment of Hardy-Weinberg equilibrium filtering in large sample Genomic studies ↗

  medRxiv · 2024
  not yet assessed
• Supplementary Figure S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S10 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S3 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S5 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S4 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S7 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S2 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S8 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S6 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S10 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S2 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Data from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S9 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S9 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S5 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S7 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S8 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Methods S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Data from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S3 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S10 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S11 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S2 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S4 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S6 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S7 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S5 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S6 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S3 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S6 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S8 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Methods S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S2 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S4 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S4 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S1 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Figure S9 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S10 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S9 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S7 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S5 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S3 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S11 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Supplementary Table S8 from Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  2024
  not yet assessed
• Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  Clinical Lymphoma Myeloma & Leukemia · 2024
  not yet assessed
• MPN-755 Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk ↗

  Clinical Lymphoma Myeloma & Leukemia · 2024
  not yet assessed
• 33. Customize your variant interpretation workflow with OpenCRAVAT ↗

  Cancer Genetics · 2024
  not yet assessed
• The challenge of chromatin model comparison and validation - a project from the first international 4D Nucleome Hackathon ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• An international consensus on effective, inclusive, and career-spanning short-format training in the life sciences and beyond ↗

  PLoS ONE · 2023 · PMID 37943810
  not yet assessed
• The GIAB genomic stratifications resource for human reference genomes ↗

  RePEc: Research Papers in Economics · 2023
  not yet assessed
• Optimizing Short-format Training: an International Consensus on Effective, Inclusive, and Career-spanning Professional Development in the Life Sciences and Beyond ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023
  not yet assessed
• The GIAB genomic stratifications resource for human reference genomes ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023
  not yet assessed
• The fourth annual Carnegie Mellon Libraries hackathon for biomedical data management, knowledge graphs, and deep learning ↗

  2023
  not yet assessed
• Plasma Proteomic Signature Predicts Risk of Myeloid Neoplasm ↗

  Blood · 2023
  not yet assessed
• Validating Subtype Specific Oncology Drug Predictions ↗

  2023
  not yet assessed
• VariantSurvival: a tool to identify genotype–treatment response ↗

  Frontiers in Bioinformatics · 2023 · PMID 37885757
  not yet assessed
• Acute and Chronic Pancreatitis Disease Prevalence, Classification, and Comorbidities: A Cohort Study of the UK BioBank ↗

  Clinical and Translational Gastroenterology · 2022 · PMID 35060944
  not yet assessed
• iCn3D: From Web-Based 3D Viewer to Structural Analysis Tool in Batch Mode ↗

  Frontiers in Molecular Biosciences · 2022 · PMID 35252351
  not yet assessed
• Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms ↗

  Blood Advances · 2022 · PMID 36170795
  not yet assessed
• The third international hackathon for applying insights into large-scale genomic composition to use cases in a wide range of organisms

  F1000Research · 2022 · PMID 36262335
  L1 59/100
• Lessons learned in virulence factor identification and data management from a hackathon on microbial virulence ↗

  F1000Research · 2022
  not yet assessed
• Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms ↗

  medRxiv · 2022
  not yet assessed
• Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes ↗

  PLoS ONE · 2021 · PMID 33411719
  not yet assessed
• A strategy for building and using a human reference pangenome ↗

  F1000Research · 2021 · PMID 34386196
  not yet assessed
• An international virtual hackathon to build tools for the analysis of structural variants within species ranging from coronaviruses to vertebrates ↗

  F1000Research · 2021
  not yet assessed
• An international virtual hackathon to build tools for the analysis of structural variants within species ranging from coronaviruses to vertebrates ↗

  F1000Research · 2021 · PMID 34621504
  not yet assessed
• iCn3D: From Web-based 3D Viewer to Structural Analysis Tool in Batch Mode ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• SnpReportR: A Tool for Clinical Reporting of RNAseq Expression and Variants ↗

  2021
  not yet assessed
• 2021 Bringing Genomics Data to the Clinic Hackathon ↗

  OSF Preprints (OSF Preprints) · 2021
  not yet assessed
• Integrated Informatics Analysis of Cancer-Related Variants ↗

  JCO Clinical Cancer Informatics · 2020 · PMID 32228266
  not yet assessed
• SeqAcademy: an educational pipeline for RNA-Seq and ChIP-Seq analysis ↗

  F1000Research · 2020 · PMID 33014338
  not yet assessed
• Jupyter notebook-based tools for building structured datasets from the Sequence Read Archive ↗

  F1000Research · 2020 · PMID 32864105
  not yet assessed
• NCBI’s Virus Discovery Codeathon: Building “FIVE” —The Federated Index of Viral Experiments API Index ↗

  Viruses · 2020 · PMID 33322070
  not yet assessed
• Jupyter notebook-based tools for building structured datasets from the Sequence Read Archive ↗

  F1000Research · 2020
  not yet assessed
• Global analysis of human SARS-CoV-2 infection and host-virus interaction ↗

  2020
  not yet assessed
• 39. Integrated informatics analysis of cancer-related variants with OpenCRAVAT ↗

  Cancer Genetics · 2020
  not yet assessed
• Methods developed during the first National Center for Biotechnology Information Structural Variation Codeathon at Baylor College of Medicine ↗

  F1000Research · 2020
  not yet assessed
• GenerGener/MASQ v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• GenerGener/SCANCNV v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• GenerGener/DeNovoSV v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• GenerGener/SWIGG v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• GenerGener/Clouseau v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• GenerGener/super-minityper v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• GenerGener/ASAP v0.1.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• Magic-BLAST, an accurate RNA-seq aligner for long and short reads ↗

  BMC Bioinformatics · 2019 · PMID 31345161
  not yet assessed
• Box, stalked, and upside-down? Draft genomes from diverse jellyfish (Cnidaria, Acraspeda) lineages: <i>Alatina alata</i> (Cubozoa), <i>Calvadosia cruxmelitensis</i> (Staurozoa), and <i>Cassiopea xamachana</i> (Scyphozoa) ↗

  GigaScience · 2019 · PMID 31257419
  not yet assessed
• geneHummus: an R package to define gene families and their expression in legumes and beyond ↗

  BMC Genomics · 2019 · PMID 31319791
  not yet assessed
• NCBI’s Virus Discovery Hackathon: Engaging Research Communities to Identify Cloud Infrastructure Requirements ↗

  Genes · 2019 · PMID 31527408
  not yet assessed
• A strategy for building and using a human reference pangenome ↗

  F1000Research · 2019
  not yet assessed
• Iron Hack - A symposium/hackathon focused on porphyrias, Friedreich’s ataxia, and other rare iron-related diseases ↗

  F1000Research · 2019 · PMID 31824661
  not yet assessed
• OpenCRAVAT, an open source collaborative platform for the annotation of human genetic variation ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• Consensus Machine Learning for Gene Target Selection in Pediatric AML Risk ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2019
  not yet assessed
• Session 3: Open Tools and Platforms ↗

  OSF Preprints (OSF Preprints) · 2019
  not yet assessed
• Prototype software for machine learning analysis of human genomes, variants, and expression! ↗

  Faculty of 1000 Research Ltd · 2019
  not yet assessed
• The Human Pangenome ↗

  Open MIND · 2019
  not yet assessed
• A Pipeline to Define Gene Families in Legumes and Beyond [R package geneHummus version 1.0.11]

  2019
  not yet assessed
• SeqAcademy: an educational pipeline for RNA-Seq and ChIP-Seq analysis ↗

  F1000Research · 2019
  not yet assessed
• Additional file 1: of Magic-BLAST, an accurate RNA-seq aligner for long and short reads ↗

  Figshare · 2019
  not yet assessed
• geneHummus: A Pipeline to Define Gene Families in Legumes and Beyond ↗

  2019
  not yet assessed
• NovoGraph: Human genome graph construction from multiple long-read de novo assemblies ↗

  F1000Research · 2018 · PMID 30613392
  not yet assessed
• NovoGraph: Genome graph construction from multiple long-read de novo assemblies ↗

  F1000Research · 2018
  not yet assessed
• SeqAcademy: an educational pipeline for RNA-Seq and ChIP-Seq analysis ↗

  F1000Research · 2018
  not yet assessed
• Matchmaking in Bioinformatics ↗

  F1000Research · 2018 · PMID 29636898
  not yet assessed
• SeqAcademy: an educational pipeline for RNA-Seq and ChIP-Seq analysis ↗

  F1000Research · 2018
  not yet assessed
• Reply to the paper: Misunderstood parameters of NCBI BLAST impacts the correctness of bioinformatics workflows ↗

  Bioinformatics · 2018 · PMID 30590429
  not yet assessed
• Magic-BLAST, an accurate DNA and RNA-seq aligner for long and short reads ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• An ATAC-seq pipeline wrapped in NextFlow that can be run by Jupyter (ATACFlow) ↗

  OSF Preprints (OSF Preprints) · 2018
  not yet assessed
• GeneHummus: A pipeline to define gene families and their expression in legumes and beyond ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• PhenotypeXpression: sub-classification of disease states using public gene expression data and literature ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Jupyterized Pipeline Generation Project

  OSF Preprints (OSF Preprints) · 2018
  not yet assessed
• NCBI-Hackathons/NovoGraph: NovoGraph 1.0.0 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2018
  not yet assessed
• Referee report. For: RSEQREP: RNA-Seq Reports, an open-source cloud-enabled framework for reproducible RNA-Seq data processing, analysis, and result reporting [version 1; referees: 2 approved with reservations] ↗

  Faculty of 1000 Research Ltd · 2018
  not yet assessed
• Referee report. For: RSEQREP: RNA-Seq Reports, an open-source cloud-enabled framework for reproducible RNA-Seq data processing, analysis, and result reporting [version 2; peer review: 2 approved] ↗

  Faculty of 1000 Research Ltd · 2018
  not yet assessed
• PubRunner: A light-weight framework for updating text mining results ↗

  F1000Research · 2017
  not yet assessed
• dbVar structural variant cluster set for data analysis and variant comparison ↗

  F1000Research · 2017 · PMID 28357035
  not yet assessed
• PubRunner: A light-weight framework for updating text mining results ↗

  F1000Research · 2017 · PMID 29152221
  not yet assessed
• DangerTrack: A scoring system to detect difficult-to-assess regions ↗

  F1000Research · 2017 · PMID 28503299
  not yet assessed
• Viewing RNA-seq data on the entire human genome

  F1000Research · 2017 · PMID 28979763
  L1 50/100
• Virus Discovery Project ↗

  Open MIND · 2017
  not yet assessed
• Extending TCGA queries to automatically identify analogous genomic data from dbGaP ↗

  F1000Research · 2017 · PMID 28794857
  not yet assessed
• Screw: tools for building reproducible single-cell epigenomics workflows ↗

  Faculty of 1000 Research Ltd · 2017
  not yet assessed
• NastyBugs: A simple method for extracting antimicrobial resistance information from metagenomes ↗

  F1000Research · 2017
  not yet assessed
• MeSHgram: An Open Source Tool to Visually Browse Co-occurrence of MeSH Terms in PubMed.

  AMIA · 2017
  not yet assessed
• Harmonizing User-defined Phenotypic Variables using Latent Semantic Analysis (LSA) to Improve Data Discoverability in dbGaP.

  AMIA · 2017
  not yet assessed
• Stage 3: ViruSpy ↗

  OSF Preprints (OSF Preprints) · 2017
  not yet assessed
• Stage 4: EndoVir ↗

  OSF Preprints (OSF Preprints) · 2017
  not yet assessed
• Stage 5: VirusFriends ↗

  OSF Preprints (OSF Preprints) · 2017
  not yet assessed
• dbVar structural variant cluster set for data analysis and variant comparison ↗

  F1000Research · 2016
  not yet assessed
• Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival ↗

  BMC Cancer · 2016 · PMID 26944546
  not yet assessed
• Closing gaps between open software and public data in a hackathon setting: User-centered software prototyping ↗

  F1000Research · 2016 · PMID 27134733
  not yet assessed
• Closing gaps between open software and public data in a hackathon setting: User-centered software prototyping ↗

  F1000Research · 2016
  not yet assessed
• MetaNetVar: Pipeline for applying network analysis tools for genomic variants analysis ↗

  F1000Research · 2016 · PMID 27158457
  not yet assessed
• A cloud-based learning environment for comparing RNA-seq aligners ↗

  F1000Research · 2016
  not yet assessed
• ISMB sequence-structure hackathon 2016! ↗

  Faculty of 1000 Research Ltd · 2016
  not yet assessed
• Additional file 1: of Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival ↗

  Figshare · 2016
  not yet assessed
• Additional file 1: of Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival ↗

  Figshare · 2016
  not yet assessed
• Building Genomic Analysis Pipelines in a Hackathon Setting with Bioinformatician Teams: DNA-seq, Epigenomics, Metagenomics and RNA-seq ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2015
  not yet assessed
• Building Genomic Analysis Pipelines in a Hackathon Setting

  2015
  not yet assessed
• Referee report. For: Evidence of polygenic selection on human stature inferred from spatial distribution of allele frequencies [version 1; referees: 1 approved with reservations] ↗

  Faculty of 1000 Research Ltd · 2015
  not yet assessed
• Effect of Domestication on the Spread of the [PIN+] Prion in<i>Saccharomyces cerevisiae</i> ↗

  Genetics · 2014 · PMID 24812307
  not yet assessed
• Faculty Opinions recommendation of Transcriptome complexity and riboregulation in the human pathogen Helicobacter pylori. ↗

  Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
  not yet assessed
• Contribution of phage‐derived genomic islands to the virulence of facultative bacterial pathogens ↗

  Environmental Microbiology · 2012 · PMID 23035931
  not yet assessed
• Referee report. For: Is the pan-genome also a pan-selectome? [v1; indexed, http://f1000r.es/Vl9wKI] ↗

  Faculty of 1000 Research Ltd · 2012
  not yet assessed
• Faculty Opinions recommendation of Cellulases: ambiguous nonhomologous enzymes in a genomic perspective. ↗

  Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2011
  not yet assessed
• Faculty Opinions recommendation of Opportunity and means: horizontal gene transfer from the human host to a bacterial pathogen. ↗

  Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2011
  not yet assessed
• Faculty Opinions recommendation of A bacterium that can grow by using arsenic instead of phosphorus. ↗

  Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2010
  not yet assessed
• A global benchmark study using affinity-based biosensors ↗

  Analytical Biochemistry · 2008 · PMID 19133223
  not yet assessed